Empresa Tauriga Sciences, Inc. Other OTC
Acciones
TAUG
US87669X2053
Farmacéuticos
Resumen de negocios
Ventas por actividad
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
E-commerce
82,0
%
| 0 | 14,7 % | 0 | 82,0 % | +579,45 % |
Wholesale
18,0
%
| 0 | 58,7 % | 0 | 18,0 % | -62,68 % |
Ventas por región
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,73 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 05/07/17 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 15/07/20 |
Adina Miles
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 08/03/21 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Director/Board Member | 46 | 08/03/21 | |
Director/Board Member | 75 | 05/08/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 299 908 214 | 299 908 214 ( 100,00 %) | 0 | 100,00 % |
Información de la empresa
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+32,36 % | 695 mil M | |
+26,51 % | 568 mil M | |
-4,40 % | 361 mil M | |
+19,46 % | 330 mil M | |
+3,50 % | 283 mil M | |
+16,34 % | 239 mil M | |
+6,68 % | 204 mil M | |
-9,08 % | 198 mil M | |
+8,62 % | 168 mil M |